Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Beyond Anecdotes: Measuring Global Health Impact in Washington State
|
Lisa Cohen |
11/18/09 |
Seattle
|
|
Cequent Seeks First Oral RNAi Trial
|
Luke Timmerman |
11/12/09 |
Boston
|
|
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer
|
Luke Timmerman |
11/10/09 |
Boston
|
|
Top 10 Highlights from FiReGlobal: Michael Dell, Lee Hartwell, Irwin Jacobs, and More
|
Gregory T. Huang |
10/16/09 |
Seattle
|
|
Lee Hood’s New Company Snags $30M to Spot Cancer and Alzheimer’s in Early Days
|
Luke Timmerman |
10/14/09 |
Seattle
|
|
Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney
|
Luke Timmerman |
10/14/09 |
Seattle
|
|
The Stimulus, UW, and Washington State
|
Ed Lazowska |
10/13/09 |
Seattle
|
|
Sage Bionetworks, Biology’s Open Source Spark, Snags “Major” Donation from Quintiles
|
Luke Timmerman |
10/06/09 |
Seattle
|
|
Hutch Pulls In $40M From Stimulus
|
Luke Timmerman |
10/05/09 |
Seattle
|
|
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/01/09 |
Seattle
|
|
Recruit Rock Star Scientists To Make Seattle Thrive as an Innovation Hub
|
Carl Weissman |
10/01/09 |
Seattle
|
|
The Quest for an HIV Vaccine
|
Lawrence Corey |
09/29/09 |
Seattle
|
|
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1)
|
Luke Timmerman |
09/23/09 |
Seattle
|
|
The Rosetta Diaspora: Genetics Talent Stays Close to Home After Merck Shuts Down in Seattle
|
Luke Timmerman |
09/02/09 |
Seattle
|
|
Targeted Growth Tinkers with Genes to See If Algae Can Fulfill Biofuel Potential
|
Luke Timmerman |
08/14/09 |
Seattle
|
|
Stephen Friend, Leaving High-Powered Merck Gig, Lights Fire for Open Source Biology Movement
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
Dendreon’s Former Boss Predicts Takeover, Covance Buys Merck Lab, How NanoString Got $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/30/09 |
Seattle
|
|
Targeted Growth Plots Future as Agricultural Biotech, Cleantech Pioneer
|
Luke Timmerman |
07/24/09 |
Seattle
|
|
UW Spinout, Beat BioTherapeutics, Aims to Make Stem Cells for Damaged Hearts
|
Luke Timmerman |
06/11/09 |
Seattle
|
|
Open Source Biology Movement Co-Founder, Merck’s Eric Schadt, Leaves for New Job
|
Luke Timmerman |
05/28/09 |
Seattle
|
|
Genologics Aims to Turn Patient Records, Genome Data into Something Biologists Can Use
|
Luke Timmerman |
05/27/09 |
Seattle
|
|
Dendreon’s Manufacturing Challenge, Archus Cuts Deep, Accelerator Company Launches & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/21/09 |
Seattle
|
|
Presage, Fred Hutch Spinoff, Aims to Show Docs Which Cancer Drugs Work, and Which Won’t
|
Luke Timmerman |
05/19/09 |
Seattle
|
|
Biotech Needs Charity, and Profit Motive, To Flourish
|
Richard Gayle |
05/11/09 |
Seattle
|
|
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
Arrowsmith Challenges Scientific Establishment With New Approach for Brain Cancer
|
Luke Timmerman |
05/04/09 |
Seattle
|
|
Microsoft Aims to Help Scientists Move Past Excel, Make Sense of Gene Data Overload
|
Luke Timmerman |
04/28/09 |
Seattle
|
|
Dendreon’s “Clear Hit” on Provenge, Oncothyreon Rides Coattails, Cell Therapeutics Nabs $15M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/16/09 |
Seattle
|
|
Hutch Cuts 83 Jobs To Cope with Drop in Philanthropy
|
Luke Timmerman |
04/15/09 |
Seattle
|
|
Obama Stimulus Plan May Generate $300M Research Windfall, UW Says
|
Luke Timmerman |
03/23/09 |
Seattle
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
